Department of Gastrointestinal Surgery, Chengdu Medical College, Chengdu 610500, China.
Int J Mol Sci. 2021 Nov 17;22(22):12403. doi: 10.3390/ijms222212403.
Ferroptosis is a novel form of regulated cell death (RCD) that is typically accompanied by iron accumulation and lipid peroxidation. In contrast to apoptosis, autophagy, and necroptosis, ferroptosis has unique biological processes and pathophysiological characteristics. Since it was first proposed in 2012, ferroptosis has attracted attention worldwide. Ferroptosis is involved in the progression of multiple diseases and could be a novel therapeutic target in the future. Recently, tremendous progress has been made regarding ferroptosis and gastrointestinal diseases, including intestinal ischemia/reperfusion (I/R) injury, inflammatory bowel disease (IBD), gastric cancer (GC), and colorectal cancer (CRC). In this review, we summarize the recent progress on ferroptosis and its interaction with gastrointestinal diseases. Understanding the role of ferroptosis in gastrointestinal disease pathogenesis could provide novel therapeutic targets for clinical treatment.
铁死亡是一种新型的细胞程序性死亡(RCD),通常伴随着铁积累和脂质过氧化。与细胞凋亡、自噬和坏死性凋亡不同,铁死亡具有独特的生物学过程和病理生理学特征。自 2012 年首次提出以来,铁死亡已引起全球关注。铁死亡参与多种疾病的进展,可能成为未来的新型治疗靶点。最近,铁死亡与胃肠道疾病的关系取得了巨大进展,包括肠缺血/再灌注(I/R)损伤、炎症性肠病(IBD)、胃癌(GC)和结直肠癌(CRC)。在这篇综述中,我们总结了铁死亡及其与胃肠道疾病相互作用的最新进展。了解铁死亡在胃肠道疾病发病机制中的作用可为临床治疗提供新的治疗靶点。